Fundz

Duoning Biotech Acquires Prefluid To Strengthen Fluid Management Solutions

PRIVATEJul 18, 2023

Acquiring Company

Duoning Biotech

Acquired Company

PreFluid

ManufacturingBiotechnologyManufacturingBiotechnology

Description

Duoning Biotechnology Co., Ltd. ("Duoning Biotech") has used Shanghai Duoning Yuexi Biological Technology Co., Ltd. ("Duoning Yuexi") to sign an agreement to acquire Changzhou PreFluid Technology Co., Ltd. ("PreFluid"), a professional manufacturer of peristaltic pumps, expanding its key product portfolio related to fluid transport and upgrading the fluid management solutions.

Quick answer

Duoning Biotech is acquiring PreFluid, announced July 18, 2023.

How much did Duoning Biotech pay for PreFluid?
The deal value was not disclosed.
What does Duoning Biotech do?
Shanghai Duoning Biotechnology Co., Ltd. is a leading one-stop shop dedicated to providing integrated bioprocess solutions from the development to the commercialization of biologics products in China.

Source: Fundz verified event record.

Other recent acquisitions in Manufacturing and Biotechnology

Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.

Who to call at Duoning Biotech, and when

When Duoning Biotech changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Duoning Biotech raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Duoning Biotech, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Duoning Biotech. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Duoning Biotech

About

Shanghai Duoning Biotechnology Co., Ltd. is a leading one-stop shop dedicated to providing integrated bioprocess solutions from the development to the commercialization of biologics products in China. We operate two business lines, bioprocess solutions and laboratory products and relative services, and seek to help partners achieve efficient, stable, high-quality and cost-controllable drug development and manufacturing processes. For more information, please visit: www.duoningbio.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Duoning Biotech makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Duoning Biotech's next move

Learn about Strategic plan

Frequently asked

Who acquired PreFluid?

PreFluid was acquired by Duoning Biotech. The deal was reported on July 18, 2023. Shanghai Duoning Biotechnology Co., Ltd. is a leading one-stop shop dedicated to providing integrated bioprocess solutions from the development to the commercialization of biologics products in China. Duoning Biotech is privately held and operates in Manufacturing.

When did Duoning Biotech acquire PreFluid?

Duoning Biotech's acquisition of PreFluid was reported on July 18, 2023. Duoning Biotechnology Co., Ltd. ("Duoning Biotech") has used Shanghai Duoning Yuexi Biological Technology Co., Ltd. ("Duoning Yuexi") to sign an agreement to acquire Changzhou PreFluid Technology Co., Ltd. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does PreFluid do?

PreFluid specializes in developing various types of peristaltic pump, and filling pump, and is a peristaltic pump manufacturer. Provide a variety of application solutions according to customer needs. It is privately held, operating in Manufacturing.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.